Biblio

Found 9 results
Filters: Author is Hollander, Z  [Clear All Filters]
2019
F. S. LeitaoFilho, Alotaibi, N. M., Ngan, D., Tam, S., Yang, J., Hollander, Z., Chen, V., Fitzgerald, J. M., Nislow, C., Leung, J. M., Man, S. F. P., and Sin, D., “Sputum microbiome is associated with 1-year mortality after chronic obstructive pulmonary disease hospitalizations”, American Journal of Respiratory and Critical Care Medicine, vol. 199, no. 10, pp. 1205-1213, 2019.
2017
Z. Hollander, DeMarco, M. L., Sadatsafavi, M., McManus, B. M., Ng, R. T., and Sin, D., “Biomarker development in COPD: moving from P values to products to impact patient care”, Chest, vol. 151, no. 2, pp. 455-467, 2017.
J. M. Leung, Chen, V., Hollander, Z., Dai, D., Tebbutt, S. J., Aaron, S. D., Vandemheen, K., Rennard, S. I., Fitzgerald, J. M., Woodruff, P. G., Lazarus, S. C., Connett, J. E., Coxson, H. O., Miller, B., Borcher, C., McManus, B. M., Ng, R. T., and Sin, D., “COPD exacerbation biomarkers validated using multiple reaction monitoring mass spectrometry”, PLoS One, vol. 11, no. 8, p. e0161129, 2017.
Y. R. Chen, Chen, V., Hollander, Z., Leipsic, J. A., Hague, C. J., DeMarco, M. L., Fitzgerald, J. M., McManus, B. M., Ng, R. T., and Sin, D., “C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations”, PLoS One, vol. 12, no. 3, p. e0174063, 2017.
C. P. Shannon, Balshaw, R., Chen, V., Hollander, Z., Toma, M., McManus, B. M., Fitzgerald, J. M., Sin, D., Ng, R. T., and Tebbutt, S. J., “Enumerateblood – an R package to estimate the cellular composition of whole blood from Affymetrix Gene ST gene expression profiles”, BMC Genomics, vol. 18, no. 43, 2017.
M. Obeidat, Nie, Y., Fisbane, N., Li, X., Bossé, Y., Joubert, P., Nickle, D. C., Hao, K., Postma, D. S., Timens, W., Sze, M. A., Shannon, C. P., Hollander, Z., Ng, R. T., McManus, B., Miller, B. E., Rennard, S., Spira, A., Hackett, T. L., Lam, W., Lam, S., Faner, R., Agusti, A., Hogg, J. C., Sin, D., and Paré, P. D., “Integrative Genomics of Emphysema-Associated Genes Reveals Potential Disease Biomarkers”, The American Journal of Respiratory Cell and Molecular Biology, vol. 57, no. 4, pp. 411-418, 2017.
A. Khakban, Sin, D., Fitzgerald, J. M., McManus, B., Ng, R., Hollander, Z., and Sadatsafavi, M., “The Projected Epidemic of COPD Hospitalizations Over the Next 15 Years: A Population Based Perspective”, American Journal of Respiratory and Critical Care Medicine, vol. 195, no. 3, pp. 287-291, 2017.
2016
R. Tkacova, Dai, D. L., Vonk, J. M., Leung, J. M., Hiemstra, P. S., van den Berge, M., Kunz, L., Hollander, Z., Tashkin, D., Wise, R., Connett, J., Ng, R., McManus, B., Man, S. F. Paul, Postma, D. S., and Sin, D., “Airway hyperresponsiveness in chronic obstructive pulmonary disease: A marker of asthma-chronic obstructive pulmonary disease overlap syndrome?”, Journal of Allergy and Clinical Immunology, vol. 138, no. 6, pp. 1571-79, 2016.
Z. Zafari, Sin, D., Postma, D. S., Löfdahl, C. G., Vonk, J., Bryan, S., Lam, S., Tammemagi, C. M., Khakban, R., Man, S. F., Tashkin, D., Wise, R. A., Connett, J. E., McManus, B., Ng, R., Hollander, Z., and Sadatsafavi, M., “Individualized prediction of lung-function decline in chronic obstructive pulmonary disease”, Canadian Medical Association Journal, vol. 188, no. 14, pp. 1004-1011, 2016.